Document is current
Any future updates will be listed below
-
Authors
Díez, Juan José https://orcid.org/0000-0002-2017-0694
Badia, Xavier
Abad, Reyes
Alerany, Carmen
Climente Martí, Mónica
Guiu, Josep Maria
Martín, Isabel
Caballero, María
Muñoz Torres, Manuel
-
Funding
Funding for this research was provided by:
Ascendis Pharma
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 2 October 2025
First Online: 24 October 2025
Declarations
:
: The author(s) declared the following potential conflicts of interest with respect to the research, authorship and/or publication of this article: Juan José Díez has received honoraria for conferences and participation in advisory boards from Ascendis Pharma. Xavier Badia is an employee of Omakase Consulting. Omakase Consulting received funds from Ascendis Pharma for the performance of this study. Reyes Abad has received honoraria for the development of this project from Ascendis Pharma and speakers’ fees from Janssen, CINFA, Astra-Zeneca, Sanofi-Aventis, Novartis. Carmen Alerany has received honoraria for the development of this project from Ascendis Pharma. Mónica Climente Martí has received honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Fresenius-Kabi, Pfizer, Alexion, Kern, Novartis and Roche and honoraria for the development of this project from Ascendis Pharma. Josep Guiu declares personal financial interests in the form of speaking/travel grants or accommodation from Amgen, AstraZeneca, Bayer, Beigene, Biogen, Boehringer Ingelheim, CSL Bering, F. Hoffmann–La Roche Ltd., Ever Pharma, GlaxoSmithKline, Gilead, Merck Sharp & Dohme, Novartis, Novonordisk, Laphysan, Pierre Fabre, Pfizer, Sandoz, Samsung Bioepis, Sanofi and Takeda and honoraria for the development of this project from Ascendis Pharma. Isabel Martín has received honoraria for the development of this project from Ascendis Pharma. María Caballero is an employee of Omakase Consulting. Omakase Consulting received funds from Ascendis Pharma for the performance of this study. Manuel Muñoz Torres has received honoraria for conferences and advisory boards and development of this study from Ascendis Pharma.
: The authors declare that no experiments on humans or animals have been carried out for this research. The authors declare that no patient data appear in this article. Full consent to participate in the study and to publish the findings was obtained from all contributors.
